GO:1902035 positive regulation of hematopoietic stem cell proliferation: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902035 describes any biological process that activates or increases the frequency, rate, or extent of hematopoietic stem cell (HSC) proliferation.
• HSC proliferation is tightly balanced between dormancy and activation, and positive regulation is required for regeneration after injury, immune reconstitution, and therapy-induced stress.
• Key positive regulators include Wnt signaling components, Rho GTPase effectors, VEGFR1-positive niche cells, and macrophage-derived signals that instruct HSC cycling.
• Exercise and systemic inflammatory cues can reprogram hematopoietic progenitors and reduce inflammatory cell production, demonstrating physiological positive regulation of HSC proliferation.
• Dysregulated positive regulation of HSC proliferation contributes to clonal hematopoiesis, leukemia, and metastatic niche formation.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of candidate regulators in HSC proliferation.
Description
Hematopoietic stem cells (HSCs) sustain lifelong blood production through a tightly controlled balance between quiescence and proliferation. The Gene Ontology term GO:1902035, positive regulation of hematopoietic stem cell proliferation, captures any process that activates or increases the frequency, rate, or extent of HSC proliferation. This term is central to understanding how the bone marrow responds to stress, injury, and immune demand, and how these responses can go awry in disease. Researchers studying regeneration, immunotherapy, and hematological malignancies need reliable models to test whether specific genes positively regulate HSC proliferation. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanisms, key genes, disease links, and experimental methods associated with GO:1902035.
positive regulation of hematopoietic stem cell proliferation At A Glance
| GO ID | GO:1902035 |
|---|---|
| GO term | positive regulation of hematopoietic stem cell proliferation |
| Ontology | biological_process |
| Synonym | activation of hematopoietic stem cell proliferation; upregulation of hematopoietic stem cell proliferation; positive regulation of hemopoietic stem cell proliferation |
| Major function | Activates or increases the frequency, rate, or extent of hematopoietic stem cell proliferation |
| Related processes | HSC dormancy maintenance, stress hematopoiesis, inflammatory cell production, pre-metastatic niche formation |
| Key regulators | Wnt signaling, Rho GTPases, VEGFR1-positive progenitors, macrophage-derived signals |
| Disease relevance | Leukemia, clonal hematopoiesis, metastatic niche, cardiovascular inflammation |
What Is GO:1902035?
GO:1902035 is a biological process term defined as any process that activates or increases the frequency, rate, or extent of hematopoietic stem cell proliferation. It includes molecular signals, cellular interactions, and systemic cues that push HSCs from dormancy into active cell cycle.
Why Is positive regulation of hematopoietic stem cell proliferation Important in Cell Biology?
Positive regulation of HSC proliferation is essential for recovery from myelosuppression, immune reconstitution after transplantation, and adaptation to systemic stress. Understanding this process helps researchers identify therapeutic targets for hematological malignancies, bone marrow failure, and inflammatory diseases.
• Enables hematopoietic recovery after irradiation or chemotherapy-induced injury.
• Supports immune reconstitution and T cell proliferative burst after checkpoint blockade.
• Links systemic exercise and metabolic cues to reduced inflammatory cell production.
• Contributes to the formation of pre-metastatic niches by VEGFR1-positive progenitors.
• Dysregulation can drive clonal expansion and leukemogenesis.
• Provides a target for CAR engineering of granulocyte-monocyte progenitors in immunotherapy.
• Involves Wnt signaling that regulates T cell differentiation and memory stem cell generation.
• Requires Rho GTPase-mediated localization and niche interactions.
• Macrophage subsets maintain HSC dormancy, and their perturbation alters proliferation.
• Serves as a biomarker and functional readout in regenerative and cancer research.
What Happens During positive regulation of hematopoietic stem cell proliferation?
Activation of quiescent HSCs
In simple terms: Dormant stem cells are awakened to start dividing.
HSCs normally reside in a dormant state in the bone marrow niche. Positive regulation begins with signals that overcome dormancy, such as stress-induced cytokines or macrophage-derived cues, leading to entry into the cell cycle. Irradiation experiments in mice show that local regulation can stimulate HSC proliferation to replenish depleted pools.
Niche and systemic instruction
In simple terms: The environment tells stem cells to proliferate.
VEGFR1-positive haematopoietic bone marrow progenitors can initiate pre-metastatic niches, demonstrating that systemic signals mobilize and instruct HSCs. Exercise reduces inflammatory cell production by instructing hematopoietic progenitor cells, showing that physiological stimuli can positively regulate HSC proliferation.
Intracellular signaling pathways
In simple terms: Inside the cell, specific pathways push the division button.
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells, indicating its role in regulating stem cell proliferation and differentiation. Rho GTPases regulate hematopoietic stem cell localization and are required for proper niche interactions that support proliferation.
Macrophage-mediated maintenance and release
In simple terms: Special immune cells keep stem cells asleep or let them wake up.
A subset of macrophages maintains HSC dormancy; their depletion or alteration can release HSCs into active proliferation. This demonstrates that positive regulation can occur by removing inhibitory signals as well as by adding stimulatory ones.
Expansion for therapy and engineering
In simple terms: Stem cells are grown in the lab for treatments.
Granulocyte-monocyte progenitors can be expanded and CAR-engineered for cellular immunotherapy, requiring controlled positive regulation of progenitor proliferation. This highlights the translational importance of understanding GO:1902035.
Key Genes Involved in GO:1902035 positive regulation of hematopoietic stem cell proliferation
The following genes and proteins are experimentally linked to positive regulation of hematopoietic stem cell proliferation based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Wnt signaling components (e.g., beta-catenin) | Promotes stem cell proliferation and memory stem cell generation | Target for modulating T cell differentiation and HSC expansion |
| Rho GTPases (e.g., Rac1, RhoA) | Regulates HSC localization and niche retention | Required for proper HSC proliferation and mobilization |
| VEGFR1 (Flt1) | Marks bone marrow progenitors that initiate pre-metastatic niches | Links HSC proliferation to metastasis |
| Macrophage-derived factors | Maintain HSC dormancy; their removal triggers proliferation | Target for modulating HSC quiescence |
| PD-1 (Pdcd1) | Regulates T cell proliferative burst after checkpoint therapy | Indirectly influences hematopoietic proliferation |
| CAR constructs | Engineer granulocyte-monocyte progenitors for immunotherapy | Requires expansion of progenitors |
| Exercise-induced factors | Reduce inflammatory cell production via progenitor instruction | Physiological regulator of HSC proliferation |
| Irradiation-responsive signals | Stimulate HSC proliferation after injury | Model for stress hematopoiesis |
| CD8+ T cells | Provide proliferative burst after PD-1 therapy | Indirectly linked to hematopoietic activation |
| Beta-catenin | Mediates Wnt signaling in stem cells | Key node in proliferation control |
| Rac1 | Rho GTPase regulating HSC localization | Modulates niche interactions |
| RhoA | Rho GTPase affecting HSC retention | Potential target for mobilization |
| Flt1 (VEGFR1) | Receptor on bone marrow progenitors | Pre-metastatic niche formation |
| Macrophage subsets | Maintain HSC dormancy | Depletion leads to proliferation |
| GM progenitors | Expandable for CAR engineering | Therapeutic source for immunotherapy |
| Inflammatory cytokines | Systemic cues that instruct HSCs | Exercise reduces inflammatory cell production |
| Stress erythropoiesis factors | Drive HSC proliferation after irradiation | Recovery from myelosuppression |
| Memory stem cell markers | Generated by Wnt signaling | Long-lived T cell responses |
How Is positive regulation of hematopoietic stem cell proliferation Regulated?
Positive regulation of HSC proliferation is controlled by a balance of stimulatory and inhibitory signals. Wnt signaling promotes proliferation and memory stem cell generation, while Rho GTPases regulate localization and niche retention. Macrophage subsets maintain dormancy, and their depletion releases HSCs into cycle. Systemic factors such as exercise reduce inflammatory cell production by instructing progenitors. Irradiation-induced stress stimulates proliferation for recovery. These layers ensure HSC pools are maintained while meeting demand.
positive regulation of hematopoietic stem cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Wnt signaling components | Leukemia, T cell memory | Knockout or overexpression in HSCs |
| Rho GTPases | HSC mobilization, leukemia | Point mutation or knockout mice |
| VEGFR1 (Flt1) | Metastasis, pre-metastatic niche | Knockout or knock-in models |
| Macrophage factors | Clonal hematopoiesis, bone marrow failure | Macrophage depletion models |
| CAR constructs | Immunotherapy for cancer | Knock-in of CAR into GM progenitors |
Leukemia and clonal hematopoiesis
Dysregulated positive regulation of HSC proliferation can lead to clonal expansion and leukemia. Macrophage-mediated maintenance of dormancy is critical; its disruption may contribute to malignant transformation. Understanding these mechanisms can inform therapies targeting leukemic stem cells.
Metastasis and pre-metastatic niche
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, linking HSC proliferation and mobilization to cancer metastasis. Targeting these progenitors may prevent metastatic spread.
Cardiovascular inflammation
Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells, demonstrating that positive regulation of HSC proliferation can be modulated to reduce disease risk.
Immunotherapy and CAR engineering
Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy requires controlled proliferation of progenitors. This approach is being developed for cancer treatment.
From positive regulation of hematopoietic stem cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate HSC proliferation? | CRISPR knockout in HSCs followed by proliferation assays |
| Does a point mutation in gene Y alter HSC cycling? | Point-mutation knock-in mice |
| Can overexpression of gene Z expand HSCs? | Overexpression via lentiviral transduction |
| Does a tagged protein localize to the niche? | Tagged knock-in for imaging |
| Does macrophage depletion activate HSCs? | Macrophage depletion in mice |
| Does exercise alter HSC proliferation? | Exercise intervention in mice |
How to Study the positive regulation of hematopoietic stem cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | HSC frequency and cell cycle status | Quantify proliferation after gene knockout |
| Bone marrow transplantation | Repopulation capacity | Assess HSC function in vivo |
| RNA-seq | Transcriptional changes | Identify pathways regulating proliferation |
| Intravital imaging | HSC localization and division | Study niche interactions |
| Macrophage depletion | Effect on HSC dormancy | Test positive regulation by removing inhibitors |
| Exercise intervention | Systemic effect on HSC proliferation | Physiological regulation |
| CAR engineering | Expansion of progenitors | Therapeutic application |
| Irradiation assays | Stress-induced proliferation | Recovery models |
Flow cytometry and cell cycle analysis
Flow cytometry with Ki-67 and Hoechst staining measures HSC proliferation status. This method is used to quantify positive regulation after genetic or pharmacological perturbation.
Bone marrow transplantation
Transplantation assays assess HSC repopulation capacity, a functional readout of proliferation and self-renewal.
RNA-seq and transcriptomics
RNA sequencing identifies gene expression changes in HSCs upon activation, revealing pathways that positively regulate proliferation.
Imaging and lineage tracing
Intravital imaging and lineage tracing visualize HSC localization and division in the niche.
How CRISPR Can Be Used to Study GO:1902035 positive regulation of hematopoietic stem cell proliferation
Knockout
CRISPR knockout of candidate genes in HSCs or progenitor cell lines can determine whether they are required for positive regulation of proliferation. For example, knocking out Rho GTPases impairs HSC localization and proliferation.
Point Mutation
Point mutations can model specific amino acid changes that alter signaling activity. This is useful for dissecting domains required for Wnt or Rho GTPase function in HSC proliferation.
Knock-in
Knock-in of reporters or tags allows visualization and tracking of HSCs. Tagged knock-in of VEGFR1 or macrophage markers can reveal niche interactions.
Overexpression
Overexpression of positive regulators, such as Wnt components or CAR constructs, can expand HSCs and progenitors for therapy.
How EDITGENE Supports positive regulation of hematopoietic stem cell proliferation Research
Researchers studying positive regulation of hematopoietic stem cell proliferation-related genes often need to determine whether a candidate gene is causally involved in HSC activation, expansion, or maintenance. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of hematopoietic stem cell proliferation research.
Frequently Asked Questions About positive regulation of hematopoietic stem cell proliferation
What is GO:1902035?
GO:1902035 is the Gene Ontology term for positive regulation of hematopoietic stem cell proliferation, defined as any process that activates or increases the frequency, rate, or extent of hematopoietic stem cell proliferation.
What genes are involved in positive regulation of hematopoietic stem cell proliferation?
Key genes include Wnt signaling components, Rho GTPases, VEGFR1, and macrophage-derived factors.
How is hematopoietic stem cell proliferation regulated?
It is regulated by a balance of stimulatory and inhibitory signals from the niche, systemic cues, and intracellular pathways such as Wnt and Rho GTPases.
What diseases are linked to dysregulated HSC proliferation?
Leukemia, clonal hematopoiesis, metastatic niche formation, and cardiovascular inflammation.
How can I study positive regulation of HSC proliferation in the lab?
Use flow cytometry, bone marrow transplantation, RNA-seq, imaging, and CRISPR models.
What is the role of macrophages in HSC dormancy?
A subset of macrophages maintains HSC dormancy; their depletion can trigger proliferation.
Does exercise affect hematopoietic stem cell proliferation?
Yes, exercise reduces inflammatory cell production by instructing hematopoietic progenitor cells.
What is the link between VEGFR1 and HSC proliferation?
VEGFR1-positive bone marrow progenitors initiate the pre-metastatic niche, linking HSC mobilization to metastasis.
How does Wnt signaling regulate HSC proliferation?
Wnt signaling arrests effector T cell differentiation and generates memory stem cells, influencing stem cell proliferation.
What CRISPR models are available for studying HSC proliferation?
Knockout, point mutation, knock-in, and overexpression models can be generated for candidate genes.
Conclusion
GO:1902035, positive regulation of hematopoietic stem cell proliferation, is a critical biological process that governs blood regeneration, immune responses, and disease progression. Understanding its mechanisms through CRISPR-based models and functional assays can reveal therapeutic targets for leukemia, metastasis, and inflammatory diseases. EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Im SJ et al.. 2016. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.. Nature 537(7620):417-421 PMID: 27501248
- 2. Yue S et al.. 2026. Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy.. Cell 189(17):5378-5395.e11 PMID: 42320470
- 3. Frodermann V et al.. 2019. Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells.. Nat Med 25(11):1761-1771 PMID: 31700184
- 4. Kaplan RN et al.. 2005. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.. Nature 438(7069):820-7 PMID: 16341007
- 5. Gattinoni L et al.. 2009. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells.. Nat Med 15(7):808-13 PMID: 19525962
- 6. Williams DA et al.. 2008. Rho GTPases and regulation of hematopoietic stem cell localization.. Methods Enzymol 439:365-93 PMID: 18374178
- 7. Chae CW et al.. 2023. The maintenance mechanism of hematopoietic stem cell dormancy: role for a subset of macrophages.. BMB Rep 56(9):482-487 PMID: 37574807
- 8. Ali AM et al.. 1989. Local regulation of haemopoietic stem cell proliferation in mice following irradiation.. Cell Tissue Kinet 22(4):333-41 PMID: 2691099
